Arthroplasty, Replacement, KneeGreenCareNCT02912806
Dartmouth-Hitchcock GreenCare Registry for Total Knee Replacement
An observational study of Arthroplasty, Replacement, Knee, run by Dartmouth-Hitchcock Medical Center.
Trial summary
Evolving reimbursement policies are driving health systems to improve quality and efficiency. Transitioning to an electronic health record (EHR) provided Dartmouth-Hitchcock Medical Center (DHMC) an opportunity to redesign staff roles and care path for Total Knee Replacement (TKR). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Arthroplasty, Replacement, Knee
- What is being tested?
- Total Knee Replacement
- Type of treatment
- Surgery or procedure
- How many people
- 545 participants
- Where
- No sites listed yet
- Study dates
- Jan 2013to Apr 2016
- How long will I take part?
- 1 Year
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients scheduling primary TKR for osteoarthritis of the knee at a regional tertiary care hospital
Who may be able to join
- Scheduled TKR
- Osteoarthritis of the knee
Who cannot join
- previous TKR on the affected knee
- diagnosis other than osteoarthritis
- age less than 18 years
- declined consent
About this study
Official title: The Dartmouth GreenCare Program: Implementation of Shared Decision Making and Patient-reported Outcomes in a Standardized Care Path for Knee Replacement
Evolving reimbursement policies are driving health systems to improve quality and efficiency. Transitioning to an electronic health record (EHR) provided Dartmouth-Hitchcock Medical Center (DHMC) an opportunity to redesign staff roles and care path for Total Knee Replacement (TKR). The organization implemented a coordinated team-based care delivery model that integrated real-time measurement of: (1) compliance with trusted guidelines, (2) process of Shared Decision-Making (SdM), and (3) use of Patient-Reported Outcomes (PROs). The investigators present the implementation protocol and data.
Read the detailed description
Patient-reported outcome measures were completed 1 month preceding TKR and also at 1 and 12 months following surgery. The primary outcome was change in physical function from baseline to 1-year following surgery in the Physical Component Summary (PCS) of the Veterans-Rand (VR-12) Survey. Preoperative measures were: (1) general demographics (patient age, sex, height, weight, body mass index (BMI); (2) treatments tried before surgery; (3) health habits (tobacco use, alcohol use); (4) pre-existing medical conditions (Charlson score); (5) physical exam findings (knee range of motion, knee laxity); (7) lab tests (hemoglobin); and (7) radiographic measures (severity of osteoarthritis on standing x-rays). Secondary outcomes included Physical Score (PS) of the Patient Reported Outcome Measurement Information System Global Survey (PROMIS-10), knee function (Knee Osteoarthritis Outcome Score, KOOS), safety (reoperations, readmissions, emergency visits, and infection) and measures of patient experience (Clinician Group and Hospital Consumer Assessment of Healthcare Providers and Systems).
- Conditions
- Arthroplasty, Replacement, Knee
- Being tested
- Total Knee Replacement
- Keywords
- Knee Arthroplasty, Total knee replacement, Knee osteoarthritis, Patient-Outcomes Measurement Program, Surgical Registries, Shared Decision Making, Patient Reported Outcomes, Patient Experience, Cohort Studies
- Medical subject headings
- Osteoarthritis, Knee
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Total Knee ReplacementProcedure or surgery
Primary total knee arthroplasty for knee osteoarthritis
What is being measured
The primary outcome is the main question the study is designed to answer.
Health Gain as measured by the change in Physical Component Summary (PCS) Score
Health Gain from baseline to 12 months (from 300 to 400 days following the date) following surgery, as measured by the change in Physical Score based on standardized US adult population benchmarks for the VR12 survey
Measured: 1-year following surgery
Secondary outcomes (15)
Health Gain as measured by the change in Global Physical Health (GPH)
Health Gain from baseline to 12 months following surgery, as measured by the change in Physical Score based on standardized US adult population benchmarks for the PRIOMIS10 survey
Measured: 1-year
Health Gain as measured by the change in Percentile Rank, TKR age and gender matched
Health Gain from baseline to 12 months following surgery, as measured by the change in Physical Score Percentile Rank based on age and gender-matched beta distributions for the Dartmouth TKR population, for the PRIOMIS10 or VR12 survey
Measured: 1 year
Emotional Health
Mental Component Summary (MCS) Score change from baseline to 12 months following surgery, as measured by the change in Mental Score based on standardized US adult population benchmarks for the PRIOMIS10 or VR12 survey
Measured: 1 year
Knee Osteoarthritis Outcome Score (KOOS)
Change in KOOS score from baseline to 12 months following surgery
Measured: 1 year
Reoperation
From 0 to 90 days following the date of surgery
Measured: 3 months
Readmission
From 0 to 90 days following the date of surgery
Measured: 3 months
ER visits after surgery
From 0 to 90 days following the date of surgery
Measured: 3 months
Infection
From 0 to 90 days following the date of surgery
Measured: 3 months
Patient Satisfaction with Hospital
HCAHPS survey in 10% random subsample completed between 20 to 40 days following the date of surgery
Measured: 1 month
Patient Satisfaction with Surgeon
Clinician Group CAHPS survey in 10% random subsample completed between 300 to 400 days following the date of surgery
Measured: 10 months
Cost of care
Episode-based costs for 0 to 90 days following the date of surgery, and also per visit outpatient costs
Measured: 3 months
Length of hospital stay
Number of days between date of admission and date of discharge
Measured: Acute hospitalization
Discharge to home
Disposition at time of discharge from acute hospitalization
Measured: Acute hospitalization
Mortality
Measured: 1 year
Range of motion
Knee range of motion measured by a clinician between 60 and 120 days following surgery
Measured: 90 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Sep 2016 (estimated)
- Study startJan 2013
- Primary completionMay 2015
- Study completionApr 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Arthroplasty, Replacement, KneeStudies of the same condition, open and under way.
- More trials run by Dartmouth-Hitchcock Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 545 participants (actual)
- Target duration
- 1 Year
Sponsor and investigators
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Sohail K Mirza, MD, MPH, Principal investigator, Dartmouth-Hitchcock Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02912806
- Sponsor's protocol ID
- CPHS23310
- Acronym
- GreenCare
- Status last verified
- Sep 2016
- First submitted
- 20 Sep 2016
- Last updated
- 23 Sep 2016
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- Yes: The consented data that has been collected will be stripped of all identifiers and kept as a dataset appropriate for sharing with future researchers for secondary analyses. A Project Proposal form and Data Use Agreement will be required.
Study at a glance
From the registry record, last updated by the sponsor on 23 Sep 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Dartmouth GreenCare Program: Implementation of Shared Decision Making and Patient-reported Outcomes in a Standardized Care Path for Knee Replacement
- ClinicalTrials.gov ID
- NCT02912806
- Acronym / sponsor ID
- GreenCare / CPHS23310
- Conditions
- Arthroplasty, Replacement, Knee
- Keywords
- Knee Arthroplasty, Total knee replacement, Knee osteoarthritis, Patient-Outcomes Measurement Program, Surgical Registries, Shared Decision Making, Patient Reported Outcomes, Patient Experience
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 545 participants (actual)
- Lead sponsor
- Dartmouth-Hitchcock Medical CenterUniversity, hospital or other
- Study start
- Jan 2013
- Primary completion
- May 2015 (actual)
- Study completion
- Apr 2016 (actual)
- First posted
- 23 Sep 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Evolving reimbursement policies are driving health systems to improve quality and efficiency. Transitioning to an electronic health record (EHR) provided Dartmouth-Hitchcock Medical Center (DHMC) an opportunity to redesign staff roles and care path for Total Knee Replacement (TKR). The organization implemented a coordinated team-based care delivery model that integrated real-time measurement of: (1) compliance with trusted guidelines, (2) process of Shared Decision-Making (SdM), and (3) use of Patient-Reported Outcomes (PROs). The investigators present the implementation protocol and data.
Detailed description
Patient-reported outcome measures were completed 1 month preceding TKR and also at 1 and 12 months following surgery. The primary outcome was change in physical function from baseline to 1-year following surgery in the Physical Component Summary (PCS) of the Veterans-Rand (VR-12) Survey. Preoperative measures were: (1) general demographics (patient age, sex, height, weight, body mass index (BMI); (2) treatments tried before surgery; (3) health habits (tobacco use, alcohol use); (4) pre-existing medical conditions (Charlson score); (5) physical exam findings (knee range of motion, knee laxity); (7) lab tests (hemoglobin); and (7) radiographic measures (severity of osteoarthritis on standing x-rays). Secondary outcomes included Physical Score (PS) of the Patient Reported Outcome Measurement Information System Global Survey (PROMIS-10), knee function (Knee Osteoarthritis Outcome Score, KOOS), safety (reoperations, readmissions, emergency visits, and infection) and measures of patient experience (Clinician Group and Hospital Consumer Assessment of Healthcare Providers and Systems).
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Year
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients scheduling primary TKR for osteoarthritis of the knee at a regional tertiary care hospital
Key inclusion criteria (2 listed)
- Scheduled TKR
- Osteoarthritis of the knee
Key exclusion criteria (4 listed)
- previous TKR on the affected knee
- diagnosis other than osteoarthritis
- age less than 18 years
- declined consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Total Knee ReplacementPrimary total knee arthroplasty for knee osteoarthritis | Procedure or surgery | – |
Primary outcome
Health Gain as measured by the change in Physical Component Summary (PCS) Score
Time frame: 1-year following surgery
Health Gain from baseline to 12 months (from 300 to 400 days following the date) following surgery, as measured by the change in Physical Score based on standardized US adult population benchmarks for the VR12 survey
15 secondary outcomes
Health Gain as measured by the change in Global Physical Health (GPH)
Time frame: 1-year
Health Gain as measured by the change in Percentile Rank, TKR age and gender matched
Time frame: 1 year
Emotional Health
Time frame: 1 year
Knee Osteoarthritis Outcome Score (KOOS)
Time frame: 1 year
Reoperation
Time frame: 3 months
Readmission
Time frame: 3 months
ER visits after surgery
Time frame: 3 months
Infection
Time frame: 3 months
Patient Satisfaction with Hospital
Time frame: 1 month
Patient Satisfaction with Surgeon
Time frame: 10 months
Cost of care
Time frame: 3 months
Length of hospital stay
Time frame: Acute hospitalization
Discharge to home
Time frame: Acute hospitalization
Mortality
Time frame: 1 year
Range of motion
Time frame: 90 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Sep 2016.
- Individual participant dataSharing planned: Yes. The consented data that has been collected will be stripped of all identifiers and kept as a dataset appropriate for sharing with future researchers for secondary analyses. A Project Proposal form and Data Use Agreement will be required.
Related trials for Arthroplasty, Replacement, Knee
RecruitingPhase 3
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Venous Thromboembolism (VTE)
Recruiting
SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty
Knee Osteoarthritis
Enrolling by invitationObservational study
Persona SoluTion PPS Femur PMCF
Rhematoid Arthritis, Osteo Arthritis of the Knee
Recruiting
ACB and iPACK Blocks With Intravenous Dexamethasone and Perineural Dexmedetomidine in Total Knee Arthroplasty
Knee Osteoarthritis
RecruitingPhase 3
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Symptomatic Venous Thromboembolism (VTE)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sohail K Mirza, MD, MPH principal investigator
Dartmouth-Hitchcock Medical Center
Questions about this trial
What is this clinical trial studying?
An observational study of Arthroplasty, Replacement, Knee, run by Dartmouth-Hitchcock Medical Center.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Health Gain as measured by the change in Physical Component Summary (PCS) Score (time frame: 1-year following surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2016.